Aquisição URGENTE de Adalimumab 20 mg/0.2 ml sol inj ser 0.2 ml SC, Adalimumab 40 mg/0.4 ml sol inj caneta 0.4 ml SC, Capecitabina 150 mg comp, Etanercept 25 mg pó sol inj fr SC, Leuprorrelina 45 mg pó sol inj ser SC e Midostaurina 25 mg cáps

ID 12199188 · Portal BASE
Price
Base Price
€869,646 .00
Effective Price
€103,530 .00 -88.1%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
AMGEN-BIO-FARMACÊUTICA LDA
NIF 502942959
Company
Dates
Publication
26 Dec 2025
Celebration
18 Dec 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
869646.0
Total effective price
103530.0
Ratio
0.119
Direction
reduction
Rule
A9 price reduction: ratio 0.119 outside [0.5, 1.5]
Detected 2026-03-06